ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Biodexa Pharmaceuticals PLC

Biodexa Pharmaceuticals PLC (BDRX)

3,99
-0,01
(-0,25%)
Geschlossen 22 Dezember 10:00PM
3,90
-0,09
(-2,26%)
Nach Börsenschluss: 1:59AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
3,99
Gebot
3,91
Fragen
4,80
Volumen
24.364
3,90 Tagesbereich 4,2151
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
4,00
Handelsbeginn
4,00
Letzte Trade
1
@
4.19
Letzter Handelszeitpunkt
Finanzvolumen
US$ 99.060
VWAP
4,0658
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
580.840
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
381k
Nettogewinn
-7,08M

Über Biodexa Pharmaceuticals PLC

Biodexa Pharmaceuticals PLC is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technolo... Biodexa Pharmaceuticals PLC is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technology focuses on long acting injectables using proprietary 3D printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. It has a pipeline of approximately eight earlier stage programs, MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma), MTX110 (Glioblastoma), MTX114 (Psoriasis), MTD211 (Schizophrenia, MDD) and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Cardiff, Gbr
Gegründet
-
Biodexa Pharmaceuticals PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BDRX. The last closing price for Biodexa Pharmaceuticals was US$4,00. Over the last year, Biodexa Pharmaceuticals shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Biodexa Pharmaceuticals currently has 580.840 shares in issue. The market capitalisation of Biodexa Pharmaceuticals is US$2,32 million.

BDRX Neueste Nachrichten

Result of General Meeting

November 22, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

BDRX - Frequently Asked Questions (FAQ)

What is the current Biodexa Pharmaceuticals share price?
The current share price of Biodexa Pharmaceuticals is US$ 3,99
How many Biodexa Pharmaceuticals shares are in issue?
Biodexa Pharmaceuticals has 580.840 shares in issue
What is the market cap of Biodexa Pharmaceuticals?
The market capitalisation of Biodexa Pharmaceuticals is USD 2,32M
What is the 1 year trading range for Biodexa Pharmaceuticals share price?
Biodexa Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals reports financial results in GBP
What is the latest annual turnover for Biodexa Pharmaceuticals?
The latest annual turnover of Biodexa Pharmaceuticals is GBP 381k
What is the latest annual profit for Biodexa Pharmaceuticals?
The latest annual profit of Biodexa Pharmaceuticals is GBP -7,08M
What is the registered address of Biodexa Pharmaceuticals?
The registered address for Biodexa Pharmaceuticals is 1 CASPIAN POINT, CASPIAN WAY, CARDIFF, CF10 4DQ
What is the Biodexa Pharmaceuticals website address?
The website address for Biodexa Pharmaceuticals is www.midatechgroup.com
Which industry sector does Biodexa Pharmaceuticals operate in?
Biodexa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock